|
KadianDrug - Kadian The trade name of the product as shown on the labeling.
Dosage -
CAPSULE, EXTENDED RELEASE; ORAL
Active Ingredient(s) -
Morphine Sulfate
Strength -
30MG
Applicant -
ALPHARMA US PHARMS
New Drug Application (NDA) Number -
020616
Product Number -
004
Therapeutic Equivalence (TE) Code -
BX
Approval Date -
Mar 9, 2001
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Alpharma Us Pharmaceuticals Division
Kadian
Kadian 20mg Capsule, Extended Release; Oral
Kadian 30mg Capsule, Extended Release; Oral Ethmozine 200mg Tablet; Oral Ethmozine 250mg Tablet; Oral Ethmozine 300mg Tablet; Oral Avinza 120mg Capsule, Extended Release; Oral Avinza 30mg Capsule, Extended Release; Oral Avinza 60mg Capsule, Extended Release; Oral Avinza 90mg Capsule, Extended Release; Oral Kadian 100mg Capsule, Extended Release; Oral NewDrugInformation |